RE:RE:Why is the share price dropping?Atleast ARLZ is already sitting at approximately $60M for 2016...
-Add in further organic growth
-Bilastine + Ibsium approval H1 2016
-Yosprala approval H2 2016
-Further acquisitions (they must have a couple in the works)
They are looking good to hit $100M revenue for 2016